Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of FOLD will rise by +0.84% over the next 2 Weeks and hit $14.53 by Tuesday, April 7, 2026. In that time frame, FOLD's share price is expected to range between $13.52 and $15.54.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 7, 2026 | 13.52 | 14.53 | 15.54 |
| Apr 6, 2026 | 13.70 | 14.54 | 15.40 |
| Apr 3, 2026 | 13.83 | 14.53 | 15.23 |
| Apr 2, 2026 | 13.92 | 14.49 | 15.04 |
| Apr 1, 2026 | 14.04 | 14.47 | 14.92 |
| Mar 31, 2026 | 14.15 | 14.47 | 14.79 |
| Mar 30, 2026 | 14.25 | 14.48 | 14.72 |
| Mar 27, 2026 | 14.33 | 14.47 | 14.62 |
| Mar 26, 2026 | 14.35 | 14.43 | 14.50 |
| Mar 25, 2026 | 14.39 | 14.41 | 14.44 |
FOLD shares fell -0.03% in Tuesday, March 24, 2026's trading session, dropping from a previous close of $14.42 to move at $14.41. The stock demonstrated notable intraday movement (see FOLD's key stats for a full breakdown), fluctuating between $14.40 and $14.41, a +0.07% trading range. While recent weeks have seen some volatility, FOLD has managed to secure a +0.28% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 3.41M shares changing hands, 756.55K more than the previous session. This amounted to $49.08M in total market activity.
Will FOLD Continue Its Upward Trend?
According to analyst ratings and projections for FOLD, Amicus Therapeutics, Inc. shares are anticipated to increase by +7.26%, potentially reaching $15.54 per share by April 7, 2026. Short-term technical indicators currently suggest a neutral sentiment for FOLD. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the FOLD stock forecast, now is a good time to buy FOLD stock because its current trading price is -0.83% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on FOLD covering social and institutional perspectives.
FOLD Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into FOLD's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 67.89% to 74.99%) indicate the stock is leaning toward a strong bullish momentum phase. The 50-day RSI, at 74.11%, indicates significant medium-term strength. However, the 100-day RSI, at 65.74%, points to growing bullish momentum over the long term. Insights into FOLD's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Amicus Therapeutics Short-Term Forecasts
FOLD Forecast For Next 5 Days
Our algorithm anticipates Amicus Therapeutics (FOLD) stock could hit $14.43 by Mar 31, 2026. This represents a +0.15% rise from today's price, following a +0.21% change over the past five days.
FOLD Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Amicus Therapeutics, Inc. (FOLD) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $14.46, which would mean a +0.35% increase from the current price of $14.41. Projections for this period range from a high of $14.52 to a low of $14.40.
FOLD Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Amicus Therapeutics's price over the next three months point to a rise. FOLD stock is expected to peak at $34.79 on Jun 12, 2026 after potentially dipping to $28.67 on May 14, 2026. On average, FOLD is likely to trade around $31.44 in the coming 90 days.
Amicus Therapeutics Stock Forecast 2025
Based on our predictive models, Amicus Therapeutics (FOLD) is expected to trade between $28.67 and $39.51 throughout 2026. This would result in an average price of $32.71, potentially offering investors a +127.00% return from current levels.
Amicus Therapeutics, Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Amicus Therapeutics, Inc. (FOLD) is positioned to show a strong performance in March 2026. The price is predicted to move between $31.09 and $34.28, settling at an average of $32.56. This could translate to a +125.95% gain.
April 2026
Based on current market signals, Amicus Therapeutics, Inc. is projected to trend april 2026. We forecast a trading range from $29.90 to $32.54, with a likely average price of $31.20. Investors could expect a potential return of +116.52%.
May 2026
Our predictive algorithms indicate Amicus Therapeutics, Inc. stock may see a shift in May 2026. The expected range spans $28.67–$32.31, with an average target of $30.19. This represents a positive outlook and a possible gain of +109.51%.
June 2026
Analyzing established trends, Amicus Therapeutics, Inc. looks set to move in June 2026. Projections place the stock between $30.90 and $34.79, averaging around $32.66. This suggests a +126.65% gain from current levels.
July 2026
Market indicators suggest Amicus Therapeutics, Inc. could experience notable changes during July 2026. Prices could fluctuate within $29.79 to $33.77, with a midpoint forecast of $31.75. The stock might deliver a +120.33% gain.
August 2026
Forecasting for August 2026, models estimate that Amicus Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $32.11 and $35.25, averaging $33.53. This signals a positive trajectory with potential returns around +132.69%.
September 2026
According to our latest forecast models, Amicus Therapeutics, Inc. (FOLD) is positioned to show a strong performance in September 2026. The price is predicted to move between $31.60 and $34.31, settling at an average of $33.10. This could translate to a +129.70% gain.
October 2026
Based on current market signals, Amicus Therapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $30.41 to $35.16, with a likely average price of $32.37. Investors could expect a potential return of +124.64%.
November 2026
Our predictive algorithms indicate Amicus Therapeutics, Inc. stock may see a shift in November 2026. The expected range spans $31.54–$36.28, with an average target of $34.12. This represents a positive outlook and a possible gain of +136.78%.
December 2026
Analyzing established trends, Amicus Therapeutics, Inc. looks set to move in December 2026. Projections place the stock between $31.35 and $39.51, averaging around $35.43. This suggests a +145.87% gain from current levels.
January 2027
Market indicators suggest Amicus Therapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $35.83 to $40.20, with a midpoint forecast of $37.95. The stock might deliver a +163.36% gain.
February 2027
Forecasting for February 2027, models estimate that Amicus Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $36.10 and $38.76, averaging $37.54. This signals a positive trajectory with potential returns around +160.51%.
March 2027
According to our latest forecast models, Amicus Therapeutics, Inc. (FOLD) is positioned to show a strong performance in March 2027. The price is predicted to move between $33.96 and $37.22, settling at an average of $35.82. This could translate to a +148.58% gain.
FOLD's history of dividends and stock splits also plays a role in long-term investor confidence.

